Program consists of emergency preparedness policies, procedures, and guidance for several healthcare provider types; Industry feedback desired during 60-day public review period through July 22 WASHINGTON
Jamie Sweeney, 64, said her eyes filled with tears when she received the diagnosis via a message on her Ipad. The Ohio native is urging doctors to withhold the information.
FDA has recently increased its efforts to support the development and approval of cell, tissue, and gene therapy (CTGT) products. This is evidenced by the upswing in CTGT approvals in.